Cited 0 times in
RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVAL
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.